Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review
<b>Background:</b> Sirolimus, a mammalian target of rapamycin inhibitor, has been widely used in pediatric patients, but the safety of sirolimus in pediatric patients has not been well determined. <b>Objective:</b> The objective of this study was to systematically evaluate pr...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-08-01
|
| Series: | Children |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9067/9/9/1295 |